Exact Mass: 409.2213

Exact Mass Matches: 409.2213

Found 31 metabolites which its exact mass value is equals to given mass value 409.2213, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Acidissiminol epoxide

N-[2-(4-{[(2E)-5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidate

C25H31NO4 (409.2253)


Acidissiminol epoxide is found in beverages. Acidissiminol epoxide is an alkaloid from fruits of Limonia acidissima (wood apple). Alkaloid from fruits of Limonia acidissima (wood apple). Acidissiminol epoxide is found in beverages and fruits.

   

3-N-Methylspiperone

8-[4-(4-fluorophenyl)-4-oxobutyl]-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one

C24H28FN3O2 (409.2165)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

Anthra(1,9-cd)pyrazol-6(2H)-one, 2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-((2-hydroxyethyl)amino)ethyl)amino)-

14-{2-[(2-hydroxyethyl)amino]ethyl}-10-({2-[(2-hydroxyethyl)amino]ethyl}amino)-14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2,4,6,9,11,13(16)-heptaen-8-one

C22H27N5O3 (409.2114)


   

Butaperazine

1-{10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazin-2-yl}butan-1-one

C24H31N3OS (409.2188)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   
   
   
   
   
   

Severin

N-[2-(4-{[(2E)-5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzamide

C25H31NO4 (409.2253)


   
   

(R,E)-ethyl 5-([1,1-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate

(R,E)-ethyl 5-([1,1-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate

C25H31NO4 (409.2253)


   

(S)-N-Fmoc-Octylglycine

(S)-N-Fmoc-Octylglycine

C25H31NO4 (409.2253)


   

5-[3-(tert-butyl)-1-(3-methylbenzyl)-1h-pyrazol-5-yl]-4-cyclohexyl-4h-1,2,4-triazole-3-thiol

5-[3-(tert-butyl)-1-(3-methylbenzyl)-1h-pyrazol-5-yl]-4-cyclohexyl-4h-1,2,4-triazole-3-thiol

C23H31N5S (409.23)


   

(R)-N-Fmoc-Octylglycine

(R)-N-Fmoc-Octylglycine

C25H31NO4 (409.2253)


   

Butaperazine

Butaperazine

C24H31N3OS (409.2188)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

(3S,4aR,6aR,12aR,12bS)-3-Hydroxy-4,4,6a,12b-tetramethyl-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydrobenzo[f]pyrano[4,3-b]chromen-11(2H)-one

(3S,4aR,6aR,12aR,12bS)-3-Hydroxy-4,4,6a,12b-tetramethyl-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydrobenzo[f]pyrano[4,3-b]chromen-11(2H)-one

C25H31NO4 (409.2253)


   

[(1S)-1-[(4-fluorophenyl)methyl]-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol

[(1S)-1-[(4-fluorophenyl)methyl]-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C24H28FN3O2 (409.2165)


   

3-((2E,6E)-9-((S)-3,3-Dimethyloxiran-2-yl)-3,7-dimethylnona-2,6-dien-1-yl)-4-hydroxy-6-(pyridin-3-yl)-2H-pyran-2-one

3-((2E,6E)-9-((S)-3,3-Dimethyloxiran-2-yl)-3,7-dimethylnona-2,6-dien-1-yl)-4-hydroxy-6-(pyridin-3-yl)-2H-pyran-2-one

C25H31NO4 (409.2253)


   

Fucalpha1-2FucalphaO[CH2]6NH2

Fucalpha1-2FucalphaO[CH2]6NH2

C18H35NO9 (409.2312)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tridec-9-enoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-tridec-9-enoate

C18H36NO7P (409.2229)


   

3-N-Methylspiperone

3-N-Methylspiperone

C24H28FN3O2 (409.2165)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

deacetylpyripyropene E

deacetylpyripyropene E

C25H31NO4 (409.2253)


An organic heterotetracyclic compound that is (3S,4aR,6aR,12aR,12bS)-3-hydroxy-4,4,6a,12b-tetramethyl-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromen-11-one substituted by a pyridin-3-yl group at position 9 (the 3S,4aR,6aR,12aR,12bS stereoisomer).

   

NA-Taurine 20:5(5Z,8Z,11Z,14Z,17Z)

NA-Taurine 20:5(5Z,8Z,11Z,14Z,17Z)

C22H35NO4S (409.2287)


   
   

ST 23:6;O2;Gly

ST 23:6;O2;Gly

C25H31NO4 (409.2253)


   

4-PPBP (maleate)

4-PPBP (maleate)

C25H31NO4 (409.2253)


4-PPBP maleate is a potent σ 1 receptor ligand and agonist. 4-PPBP maleate is a non-competitive, selective NR1a/2B NMDA receptors (expressed in Xenopus oocytes) antagonist. 4-PPBP maleate provides neuroprotection[1][2][3].

   

n-[2-(4-{[(2e,4r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

n-[2-(4-{[(2e,4r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C25H31NO4 (409.2253)


   

n-[2-(4-{[5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

n-[2-(4-{[5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C25H31NO4 (409.2253)


   

n-[2-(4-{[(2e)-5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

n-[2-(4-{[(2e)-5-(3,3-dimethyloxiran-2-yl)-4-hydroxy-3-methylpent-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C25H31NO4 (409.2253)


   

methyl (2z,4r,5s,6e)-3,5-dimethoxy-4-methyl-7-[2-(6-methylheptyl)-1,3-thiazol-4-yl]hepta-2,6-dienoate

methyl (2z,4r,5s,6e)-3,5-dimethoxy-4-methyl-7-[2-(6-methylheptyl)-1,3-thiazol-4-yl]hepta-2,6-dienoate

C22H35NO4S (409.2287)